Blood salt levels and kidney injury after clot removal for stroke
Part of Brain & nervous system, Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at whether changes in blood electrolyte levels (like sodium and potassium) after stroke treatment can predict kidney damage caused by the contrast dye used during the procedure. If you've had endovascular treatment for an ischemic stroke, your data might help improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have been diagnosed with an acute ischemic stroke (a stroke from a blocked artery).
- You had endovascular treatment (a procedure to remove the clot from your brain).
- Your kidneys were healthy before the stroke treatment — no pre-existing kidney disease.
- You have not had a heart attack or a stroke before this one.
- You have no known allergy to contrast dye, and you did not receive contrast dye within the two weeks before your procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether the time from a heart attack (STEMI) until the procedure to open the blocked artery affects the risk of kidney damage from the contrast dye used during the procedure. It may help doctors predict and prevent kidney problems in heart attack patients.
This study looks at whether the ratio of uric acid to albumin in your blood before a procedure that uses contrast dye can help predict if you might develop kidney damage afterward. It aims to find a simple way to identify patients at higher risk so they can be monitored more closely.
This trial tests if drinking beetroot juice can help protect your kidneys from damage caused by the dye used during heart procedures. It is for people hospitalized with a certain type of heart attack who are at moderate to high risk of kidney problems.
This trial tests whether using a much smaller amount of contrast dye for an invasive heart scan is safer for people with acute kidney injury (AKI). It may help reduce further kidney stress while still allowing doctors to look at coronary (heart) arteries.
This study looks at people with acute (sudden) kidney injury, based on changes in a blood test called creatinine. By tracking these patterns during hospitalization, it may help improve how acute kidney injury is identified and managed.
This study looks at whether the amount of contrast dye used in a CT scan can predict kidney injury. It will follow your kidney function with a blood test after your scan, which may help identify patients at risk of kidney problems.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.